RecruitingNot applicableNCT06685120

Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Istituto Ortopedico Rizzoli
Principal Investigator
Davide Reale, MD
Istituto Ortopedico Rizzoli - Argenta
Intervention
PRP + HA injection(combination_product)
Enrollment
288 target
Eligibility
40-75 years · All sexes
Timeline
20252029

Study locations (2)

Collaborators

University Hospital of Ferrara

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06685120 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials